GlassScriptPhysician profile
Ladonna Crews
NPI 1003866005
$1,844.49
in general payments reported to CMS, 2019-2025
22 companies · $332 in 2025
The $332 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2021: $52.33 · 2022: $146 · 2023: $237 · 2024: $554 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $277.72 | 2023-2025 | Azstarys |
| Biogen, INC. | $246.73 | 2019 | |
| Supernus Pharmaceuticals, INC. | $210.87 | 2024 | Qelbree |
| Sanofi Pasteur INC. | $181.37 | 2019-2025 | |
| Glaxosmithkline, LLC. | $167.91 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $134.65 | 2019-2023 | Kristalose |
| Sanofi-Aventis U.S. LLC | $116.65 | 2025 | |
| Merck Sharp & Dohme LLC | $90.08 | 2022-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Genentech USA, INC. | $64.33 | 2024 | Xolair |
| Genzyme Corporation | $57.10 | 2019-2023 | |
| Sobi, INC | $53.61 | 2019-2023 | |
| Pfizer INC. | $40.71 | 2019-2022 | |
| Rhythm Pharmaceuticals, INC. | $36.30 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $27.12 | 2024 | Dupixent |
| Ars Pharmaceuticals Operations, INC. | $24.80 | 2025 | Neffy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ptc Therapeutics, INC. | $23.20 | 2023 | |
| Seqirus USA INC | $21.20 | 2024 | Flucelvax |
| Tris Pharma INC | $16.71 | 2025 | Dyanavel Xr |
| Biomerieux INC | $14.40 | 2023 | |
| Acadia Pharmaceuticals INC | $14.05 | 2023 | Daybue |
| Pbg Puerto Rico LLC | $12.64 | 2021 | |
| Sarepta Therapeutics, INC. | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ladonna Crews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.